Laparoscopic Supracervical Hysterectomy and Sacropexy Versus Hysteropexy Study
- Conditions
- Uterus Prolapse
- Interventions
- Procedure: Laparoscopic Supracervical Hysterectomy and SacropexyProcedure: Laparoscopic Hysteropexy
- Registration Number
- NCT02345954
- Lead Sponsor
- Kantonsspital Aarau
- Brief Summary
The purpose of this study is to compare the operative, anatomic functional outcome as well as the subjective outcome of laparoscopic supracervical hysterectomy and sacropexy compared to laparoscopic hysteropexy (conserving the uterus).
The investigators expect that both laparoscopic procedures are equal in regards to operation time, complication rate, anatomic and functional outcome as well as subjective outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
- Patients older than 18 years
- Symptomatic uterus prolapse (uterus < 300g)
- Patient able to sign the informed consent and to fulfil the follow up visits
-
Indication: Pathologies of the uterus (postmen. bleeding, high endometrium at ultrasound (>5 mm), abnormal PAP smear in the last 5 years, bleeding anomalies in premenopausal patients
-
General medical contraindications to a surgical operation
- tumor/ malignant disease
- bacterial infection at time of surgery
- drug or medication abuse at time or just before surfer
-
Disease which would make a correct assessment of the patient impossible (e.g. psychiatric condition)
-
Known hypersensitivity to the implanted materials
-
Immaturity, inability to answer/understand questions
-
Planned pregnancy
-
Participation to other studies (drugs or medical techniques) which could influence the results of this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Supracervical Hysterectomy and Sacropexy Laparoscopic Supracervical Hysterectomy and Sacropexy Laparoscopic Supracervical Hysterectomy and Sacropexy Hysteropexy Laparoscopic Hysteropexy Laparoscopic Hysteropexy
- Primary Outcome Measures
Name Time Method Operation time expected average of 150 minutes Comparison of operation time in the 2 arms of the study
- Secondary Outcome Measures
Name Time Method Intra- and postoperative complication rate 1 year Duration of anaesthesia expected average of 200 minutes IUGA Pelvic Organ Prolapse Quantification (POP-Q) 8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention Quality of Life 8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention EQ-5D-5L questionnaire
Patient satisfaction after surgery At follow up 6 weeks, 6 months and 12 months after intervention Bladder and bowel function, Prolapse symptoms, Sexuality 8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention Assessed via Pelvic Function Questionnaire
Trial Locations
- Locations (1)
Kantonsspital Aarau
🇨ðŸ‡Aarau, Aargau (AG), Switzerland